Happy Pharmaz Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.84 M
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.50 M
- Revenue Growth %
- Profit Growth -996.64%
- Ebitda -32.56%
- Net Worth -1.42%
- Total Assets -7.55%
About Happy Pharmaz
Happy Pharmaz Private Limited (HPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 May 2008 and has a history of 16 years and eight months. Its registered office is in Pune, Maharashtra, India.
The Corporate was formerly known as Happy Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.84 M.
The company currently has active open charges totaling ₹7.50 M.
Supriya Jha and Santosh Jha serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24239PN2008PTC132053
-
Company No.
132053
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 May 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Happy Pharmaz?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Supriya Jha
|
Director | 01-Dec-2012 | Current |
|
Santosh Jha
|
Director | 19-May-2008 | Current |
Financial Performance of Happy Pharmaz.
Happy Pharmaz Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 996.64% decrease in profit. The company's net worth dipped by a decrease of 1.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Happy Pharmaz?
In 2019, Happy Pharmaz had a promoter holding of 83.09% and a public holding of 16.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Tech Takuma Solutions Private LimitedSupriya Jha and Santosh Jha are mutual person
Charges (Loans)
₹7.50 M
₹0
Charges Breakdown by Lending Institutions
- Union Bank Of India : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jan 2013 | Union Bank Of India | ₹7.50 M | Open |
How Many Employees Work at Happy Pharmaz?
Happy Pharmaz has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Happy Pharmaz, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Happy Pharmaz's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
